Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q3 2022 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2022-11-14

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $130M (100.0% shares, 0.0% debt)

Holdings (14)

ACRS Aclaris Therapeutics, Inc. 15.2%

Value $19.8M Shares 1,258,243 Est. Cost $19.56 Unrealized -19.4%

— Theseus Pharmaceuticals, Inc. 14.9%

Value $19.34M Shares 3,335,346 Est. Cost $12.42 Unrealized —

HIMS Hims & Hers Health, Inc. 14.2%

Value $18.52M Shares 3,319,786 Est. Cost $9.03 Unrealized -33.3%

— Pardes Biosciences Inc 13.4%

Value $17.39M Shares 9,400,515 Est. Cost $16.37 Unrealized —

— Kinnate Biopharma Inc. 8.0%

Value $10.46M Shares 875,001 Est. Cost $39.78 Unrealized —

— Somalogic, Inc. 7.8%

Value $10.2M Shares 3,516,472 Est. Cost $12.39 Unrealized —

CMPX Compass Therapeutics, Inc. 7.7%

Value $10.03M Shares 4,400,000 Est. Cost $3.29 Unrealized -15.8%

— Adicet Bio, Inc. 7.4%

Value $9.67M Shares 680,000 Est. Cost $17.49 Unrealized —

IVVD Invivyd, Inc. 3.4%

Value $4.482M Shares 1,431,826 Est. Cost $34.15 Unrealized -88.3%

— Gemini Therapeutics, Inc. 3.1%

Value $3.994M Shares 2,435,125 Est. Cost $13.55 Unrealized —

QSI Quantum-Si Incorporated 2.0%

Value $2.542M Shares 924,379 Est. Cost $10.48 Unrealized -69.5%

ENTA Enanta Pharmaceuticals, Inc. 1.7%

Value $2.192M Shares 42,250 Est. Cost $65.07 Unrealized -10.2%

— 23andMe Holding Co. 0.9%

Value $1.164M Shares 406,913 Est. Cost $11.69 Unrealized —

PHVS Pharvaris N.V. 0.2%

Value $262K Shares 34,142 Est. Cost $31.46 Unrealized -50.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$19.8M	15.2%	$19.56	-19.4%	COM	00461U105
—	Theseus Pharmaceuticals, Inc.	3,335,346	$19.34M	14.9%	$12.42	—	COM	88369M101
HIMS	Hims & Hers Health, Inc.	3,319,786	$18.52M	14.2%	$9.03	-33.3%	COM CL A	433000106
—	Pardes Biosciences Inc	9,400,515	$17.39M	13.4%	$16.37	—	COM	69945Q105
—	Kinnate Biopharma Inc.	875,001	$10.46M	8.0%	$39.78	—	COM	49705R105
—	Somalogic, Inc.	3,516,472	$10.2M	7.8%	$12.39	—	COM CL A	83444K105
CMPX	Compass Therapeutics, Inc.	4,400,000	$10.03M	7.7%	$3.29	-15.8%	COM	20454B104
—	Adicet Bio, Inc.	680,000	$9.67M	7.4%	$17.49	—	COM	007002108
IVVD	Invivyd, Inc.	1,431,826	$4.482M	3.4%	$34.15	-88.3%	COM	00534A102
—	Gemini Therapeutics, Inc.	2,435,125	$3.994M	3.1%	$13.55	—	COM	36870G105
QSI	Quantum-Si Incorporated	924,379	$2.542M	2.0%	$10.48	-69.5%	COM CL A	74765K105
ENTA	Enanta Pharmaceuticals, Inc.	42,250	$2.192M	1.7%	$65.07	-10.2%	COM	29251M106
—	23andMe Holding Co.	406,913	$1.164M	0.9%	$11.69	—	COM CL A	90138Q108
PHVS	Pharvaris N.V.	34,142	$262K	0.2%	$31.46	-50.4%	COM	N69605108